Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tong Cheng

Showing results (361-370 of 392) with videos related to

Pageof 40
Sort By:
Clinical Epigenetics|May 26, 2020
Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer typesRulong Shen, Tong Cheng, Chuanliang Xu, et al.
Cancer Communications (London, England)|October 10, 2024
Genomic imprinting biomarkers for cervical cancer risk stratificationXue Xiao, Wei Wang, Peng Bai, et al.
Nature Microbiology|November 7, 2018
Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralizationQingbing Zheng, Rui Zhu, Longfa Xu, et al.
Cellular & Molecular Immunology|March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.
Clinical Epigenetics|December 15, 2021
Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodulesJian Zhou, Tong Cheng, Xing Li, et al.
Cell Reports|May 20, 2022
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including OmicronSiling Wang, Hui Sun, Yali Zhang, et al.
Cell Host & Microbe|February 7, 2020
Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16Maozhou He, Longfa Xu, Qingbing Zheng, et al.
Signal Transduction and Targeted Therapy|May 3, 2024
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effectsRao Fu, Ruoyao Qi, Hualong Xiong, et al.
Nature Communications|March 3, 2021
The prevalence of antibodies to SARS-CoV-2 among blood donors in ChinaLe Chang, Wangheng Hou, Lei Zhao, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
Pageof 40

Showing results (361-370 of 392) with videos related to

Sort By:
Pageof 40
Clinical Epigenetics|May 26, 2020
Novel visualized quantitative epigenetic imprinted gene biomarkers diagnose the malignancy of ten cancer typesRulong Shen, Tong Cheng, Chuanliang Xu, et al.
Cancer Communications (London, England)|October 10, 2024
Genomic imprinting biomarkers for cervical cancer risk stratificationXue Xiao, Wei Wang, Peng Bai, et al.
Nature Microbiology|November 7, 2018
Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralizationQingbing Zheng, Rui Zhu, Longfa Xu, et al.
Cellular & Molecular Immunology|March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.
Clinical Epigenetics|December 15, 2021
Epigenetic imprinting alterations as effective diagnostic biomarkers for early-stage lung cancer and small pulmonary nodulesJian Zhou, Tong Cheng, Xing Li, et al.
Cell Reports|May 20, 2022
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including OmicronSiling Wang, Hui Sun, Yali Zhang, et al.
Cell Host & Microbe|February 7, 2020
Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16Maozhou He, Longfa Xu, Qingbing Zheng, et al.
Signal Transduction and Targeted Therapy|May 3, 2024
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effectsRao Fu, Ruoyao Qi, Hualong Xiong, et al.
Nature Communications|March 3, 2021
The prevalence of antibodies to SARS-CoV-2 among blood donors in ChinaLe Chang, Wangheng Hou, Lei Zhao, et al.
The Pediatric Infectious Disease Journal|February 18, 2026
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b TrialLingxian Qiu, Hongxing Pan, Qi Liang, et al.
Pageof 40